| 11.08.2022 14:20:49 | |
|---|---|
| Cena | |
| 163,34 EUR | |
| Změna | -1,34% (-2,22) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Stuttgart |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 435.712 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 163,36 EUR (2.000) |
| Prodej (částka) | 163,64 EUR (2.000) |
| Otevírací cena | 165,50 EUR |
| Max | 165,50 EUR |
| Min | 162,94 EUR |
| Závěrečná cena (předchozí den) | 165,56 EUR |
| Cena vážená obchodovaným objemem | - |
| Objem (kusy) | 114 |
| Obchodovaný objem | 18.650,26 |
| Počet obchodů | 6 |
| Poslední zobchodovaný počet | 10 |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 08.08.2022 |
|
Global Equity Ratings |
|
| 25.07.2022 |
|
Global Equity Ratings |
|
| 19.07.2022 |
|
Global Equity Ratings |
|
| 29.06.2022 |
|
Global Equity Ratings |
|
| 25.05.2022 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 11.08.2022 | 17:29 | 163,92 EUR | 1,18 | 460 |
| Vienna Stock Exchange | 11.08.2022 | 17:32 | 163,80 EUR | 0,00 | 2 |
| Tradegate | 11.08.2022 | 17:29 | 164,00 EUR | 2,46 | 227 |
| Stuttgart | 11.08.2022 | 14:20 | 163,34 EUR | 0,02 | 6 |
| SIX Swiss Exchange | 30.06.2022 | 17:36 | 168,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 11.08.2022 | 17:35 | 168,915 USD | 507,06 | 50.786 |
| Munich | 11.08.2022 | 08:02 | 165,90 EUR | 0,00 | 1 |
| London Stock Exchange | 11.08.2022 | 17:35 | 170,64 USD | 0,01 | 11 |
| Hanover | 11.08.2022 | 08:01 | 165,96 EUR | 0,00 | 1 |
| Hamburg | 11.08.2022 | 08:01 | 165,96 EUR | 0,00 | 1 |
| Frankfurt | 11.08.2022 | 17:30 | 163,96 EUR | 0,19 | 21 |
| Duesseldorf | 11.08.2022 | 16:01 | 162,40 EUR | 0,00 | 7 |
| Berlin | 11.08.2022 | 16:42 | 164,28 EUR | 0,00 | 3 |
| 11.08.2022 14:20:49 | |
|---|---|
| Cena | |
| 163,34 EUR | |
| Změna | -1,34% (-2,22) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | Stuttgart |
| Měna | EUR |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 435.712 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 163,36 EUR (2.000) |
| Prodej (částka) | 163,64 EUR (2.000) |
| Otevírací cena | 165,50 EUR |
| Max | 165,50 EUR |
| Min | 162,94 EUR |
| Závěrečná cena (předchozí den) | 165,56 EUR |
| Cena vážená obchodovaným objemem | - |
| Objem (kusy) | 114 |
| Obchodovaný objem | 18.650,26 |
| Počet obchodů | 6 |
| Poslední zobchodovaný počet | 10 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +11,82% | +11,73% | +40,04% |
| Výkonn. (abs.) | +17,50 | +17,38 | +47,34 |
| Beta | 0,33 | 0,30 | 0,63 |
| Volatilita | 23,06 | 20,05 | 22,96 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 167,04 EUR (680) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 171,14 EUR (242) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 167,86 EUR (305) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 154,64 EUR (494) |
| YTD Max| datum | 177,70 EUR (12.07.2022) |
| YTD Min | datum | 133,52 EUR (21.02.2022) |
| 52týdenní max. | datum | 177,70 EUR (12.07.2022) |
| 52týdenní min. | datum | 133,52 EUR (21.02.2022) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| Alex Gorsky | Chairman of Board of Directors |
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |